New CEO at Pharmacolog AB
Per Persson has been appointed as CEO at Pharmacolog AB. Per Persson has a long experience from international business and the medical device industry.
Per joins Pharmacolog with more than 30 years experience from the Medtech industry, including international leadership roles with Boston Scientific and St. Jude Medical.
Before joining Pharmacolog Per was the CEO of Acarix AB, a Swedish company within the field of coronary diagnostics, listed at Nasdaq First North. From 2012 to 2016 he was part of the senior management at Atos Medical, a successful exit by EQT in 2016.
Per’s career includes general management and senior leadership, international sales and marketing. Prior assignments have included positions in London and Brussels.
Per Persson comments:” I am looking forward to join Pharmacolog, a company that has developed market leading technologies of the necessary and vital control of pharmaceuticals and patient protection. The market dynamics are strong and are supporting innovation in the area. The market is fast growing”.
Erik Hedlund, the chairman comments: ” Per Persson’s long experience from med tech and international business will be of utmost importance for the further development to new markets in Europe, USA and East Asia. New partnerships will be established. We expect his skills and energy to be vital for the further development of the company.
At the same time we want to thank Mats Högberg for his 7 years with the company. An innovative program for quality control of drugs has been developed. A number of reference systems has been installed worldwide.”
For more information contact:
Erik Hedlund, Chairman
Phone: +46 70-382 0841
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on January 9th, 2023 at 14:00.
About Pharmacolog AB
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.
Further information regarding the company is available at http://www.pharmacolog.com.
The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.